Bridgewater, MA -- (SBWIRE) -- 04/09/2013 -- The automated StockConsultant latest screen has a found biotech company that provides drugs for the treatment of cancer Oncothyreon Inc (USA) (NASDAQ:ONTY) nearing a breakout above 2.4 and into the large upside price gap.
ONTY stock price is up 9.3% to 2.36 with 95.1% higher volume and is at resistance just below the large price gap that extends to 4. The stock is under watch for a breakout above 2.4 and into the gap with a target of 2.81 for a 19.1% gain.
Read the full ONTY StockConsultant Report
StockConsultant.com provides automated stock consulting reports and an advanced screener on over 6000 US equities. Each detailed stock report contains easy to use technical analysis indicators, charts, and news to fine tune stock entry and exit price levels. Completing the tools is a daily "Stocks to Watch" list, real time portfolio (show up to 35 stock charts simultaneously) and keyboard controlled QuickCharts.
Disclosure: StockConsultant.com and its employees are not registered investment advisors and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Please check with a registered investment advisor before making any investment decisions. For our full disclaimer please visit www.stockconsultant.com/disclaimerpage.html
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)